-
Basel, September 1, 2022 — Novartis today announced that James (Jay) E. Bradner, M.D., will step down from the Executive Committee of Novartis (ECN), effective October 31st after seven years leading research at Novartis. Fiona H. Marshall, Ph.D., currently Senior Vice President and Global Head of Discovery Sciences, Preclinical Development and…Women in ScienceDrug DiscoveryBiomedical Research
-
Biomedical ResearchNovartis Institutes for BioMedical ResearchScientific ResearchDrug DevelopmentWomen in Science
-
Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.
Biomedical ResearchData ScienceDrug DevelopmentDrug DiscoveryEmerging Technology -
Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.
Biomedical ResearchCOVID-19Drug DiscoveryNovartis Institutes for BioMedical ResearchScientific Research -
Basel, October 28, 2020 — Novartis and Molecular Partners AG today announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’ anti-COVID-19 DARPin® program, consisting of two therapeutic candidates, MP0420 and MP0423. The collaboration aims to leverage Molecular Partners’…Reimagine MedicineInfectious DiseasesGlobal Health PartnershipsBiomedical Research
-
Holzkirchen, May 3, 2021 – Sandoz, a Novartis division, today announced progress in the late-stage clinical development program for its proposed biosimilar aflibercept. Sandoz will begin enrolling the first patient in MYLIGHT, a clinical Phase III confirmatory efficacy and safety study, shortly1.OphthalmologyDrug DiscoveryBiomedical Research
-
Biomedical ResearchChronic IllnessInnovationOncologyPatient VoicesWorking at Novartis
-
Combination of two compounds shows promise in the lab
Access to HealthcareBiomedical ResearchCancerChronic IllnessDiseases -
Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.
Biomedical ResearchDigitalDiseasesDrug DiscoveryEmerging TechnologyNovartis Institutes for BioMedical Research -
The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.
Biomedical ResearchDrug DiscoveryInnovationNovartis Institutes for BioMedical ResearchWorking at Novartis -
University students majoring in the life sciences or business often have trouble imagining the direction of their careers.
Biomedical ResearchLocal ImpactWorking at Novartis -
Zebrafish imaging sheds light on human neurological conditions.
Biomedical ResearchDrug DiscoveryNeuroscienceNovartis Institutes for BioMedical ResearchPostdoc ProgramGenetic Disease
Pagination
- 1
- 2
- 3
- 4
- 5
- › Next page